Yes. Semaglutide is FDA-approved for chronic weight management in adults without diabetes under the brand name Wegovy.

Yes, semaglutide and most antibiotics can be taken together.

No. Semaglutide is contraindicated during pregnancy.

For three years semaglutide was the standard. Wegovy hit the market in 2021 with the STEP 1 trial showing 14.9% mean weight loss at 68 weeks.

Semaglutide is the most widely used GLP-1 medication on the market, with FDA approval for diabetes, obesity, and cardiovascular risk reduction.

Semaglutide is a weekly injectable GLP-1 agonist with established efficacy and FDA approval for diabetes, obesity, and cardiovascular risk reduction.

Liraglutide was the breakthrough GLP-1 of its decade.

Introduction Semaglutide isn’t FDA-approved for type 1 diabetes, but endocrinologists prescribe it off-label for select T1D patients with obesity or insulin resistance. The drug…

Introduction Patients switch between semaglutide formulations and other GLP-1 drugs for several reasons: insurance changes, cost, side effect tolerance, plateau on the current drug,…